ASGCT 2026

May 12-14, 2026, Boston, Massachusetts

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. Visit us at booth 1049 to learn about our integrated products, manufacturing and testing to help advance your therapy to patients.

Don't miss our scheduled presentations during the conference:

Tuesday, May 12th:

3:45-4:00pm - Tools and Tech Forum - Exhibit Hall Presentation Theater

Title: Integrating NGS Identity Testing for Robust Potency Assurance in AAV Therapeutics

Presenter: Alexander Barron, PhD - Scientist, Custom NGS Assays - Merck

Wednesday, May 13th:

11:15-11:45am - Sponsored Symposium - Room 109AB

Title: To 1000L and Beyond: Innovating AAV Manufacturing for the Next Wave of Gene Therapies

Presenter: Laura Juckem, PhD - Vice President, Research & Development - Mirus Bio now part of Merck

3:30-4:00pm - Sponsored Symposium - Room 109AB

Title: Harnessing Oncolytic Reovirus to Remodel Tumor Microenvironments through TLR3 Activation

Presenter: Richard Trauger - Executive Director Translational Science - Oncolytics Biotech; sponsored by Merck